Literature DB >> 11462233

Using linked markers to infer the age of a mutation.

B Rannala1, G Bertorelle.   

Abstract

Advances in sequencing and genotyping technologies over the last decade have enabled geneticists to easily characterize genetic variation at the nucleotide level. Hundreds of genes harboring mutations associated with genetic disease have now been identified by positional cloning. Using variation at closely linked genetic markers, it is possible to predict the times in the past at which particular mutations arose. Such studies suggest that many of the rare mutations underlying human genetic disorders are relatively young. Studies of variation at genetic markers linked to particular mutations can provide insights into human geographic history, and historical patterns of natural selection and disease, that are not available from other sources. We review two approaches for estimating allele age using variation at linked genetic markers. A phylogenetic approach aims to reconstruct the gene tree underlying a sample of chromosomes carrying a particular mutation, obtaining a "direct" estimate of allele age from the age of the root of this tree. A population genetic approach relies on models of demography, mutation, and/or recombination to estimate allele age without explicitly reconstructing the gene tree. Phylogenetic methods are best suited for studies of ancient mutations, while population genetic methods are better suited for studies of recent mutations. Methods that rely on recombination to infer the ages of alleles can be fine-tuned by choosing linked markers at optimal map distances to maximize the information available about allele age. A limitation of methods that rely on recombination is the frequent lack of a fine-scale linkage map. Maximum likelihood and Bayesian methods for estimating allele age that rely on intensive numerical computation are described, as well as "composite" likelihood and moment-based methods that lead to simple estimators. The former provide more accurate estimates (particularly for large samples of chromosomes) and should be employed if computationally practical. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11462233     DOI: 10.1002/humu.1158

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  21 in total

1.  New contributions to the study of common double mutants in the human LDL receptor gene.

Authors:  M Teresa Tejedor; Ana Cenarro; Diego Tejedor; Marianne Stef; Lourdes Palacios; Isabel de Castro; Angel L García-Otín; Luis V Monteagudo; Fernando Civeira; Miguel Pocovi
Journal:  Naturwissenschaften       Date:  2011-09-21

2.  The pedigree rate of sequence divergence in the human mitochondrial genome: there is a difference between phylogenetic and pedigree rates.

Authors:  Neil Howell; Christy Bogolin Smejkal; D A Mackey; P F Chinnery; D M Turnbull; Corinna Herrnstadt
Journal:  Am J Hum Genet       Date:  2003-02-04       Impact factor: 11.025

3.  On the use of star-shaped genealogies in inference of coalescence times.

Authors:  Noah A Rosenberg; Aaron E Hirsh
Journal:  Genetics       Date:  2003-08       Impact factor: 4.562

4.  Dating rare mutations from small samples with dense marker data.

Authors:  Luke C Gandolfo; Melanie Bahlo; Terence P Speed
Journal:  Genetics       Date:  2014-05-30       Impact factor: 4.562

5.  Haplotype analyses, mechanism and evolution of common double mutants in the human LDL receptor gene.

Authors:  M T Tejedor; A Cenarro; D Tejedor; M Stef; R Mateo-Gallego; I de Castro; A L García-Otin; L V Monteagudo; F Civeira; M Pocovi
Journal:  Mol Genet Genomics       Date:  2010-04-29       Impact factor: 3.291

6.  In defence of model-based inference in phylogeography.

Authors:  Mark A Beaumont; Rasmus Nielsen; Christian Robert; Jody Hey; Oscar Gaggiotti; Lacey Knowles; Arnaud Estoup; Mahesh Panchal; Jukka Corander; Mike Hickerson; Scott A Sisson; Nelson Fagundes; Lounès Chikhi; Peter Beerli; Renaud Vitalis; Jean-Marie Cornuet; John Huelsenbeck; Matthieu Foll; Ziheng Yang; Francois Rousset; David Balding; Laurent Excoffier
Journal:  Mol Ecol       Date:  2010-01-11       Impact factor: 6.185

7.  Characterization and prevalence of two novel CHEK2 large deletions in Greek breast cancer patients.

Authors:  Paraskevi Apostolou; Florentia Fostira; Vasiliki Mollaki; Angeliki Delimitsou; Metaxia Vlassi; George Pentheroudakis; Eleni Faliakou; Panagoula Kollia; George Fountzilas; Drakoulis Yannoukakos; Irene Konstantopoulou
Journal:  J Hum Genet       Date:  2018-05-22       Impact factor: 3.172

8.  A Founder Effect for the HGD G360R Mutation in Italy: Implications for a Regional Screening of Alkaptonuria.

Authors:  Berardino Porfirio; Roberta Sestini; Greta Gorelli; Miriam Cordovana; Alessandro Mannoni; Jeanette L Usher; Wendy J Introne; William A Gahl; Thierry Vilboux
Journal:  JIMD Rep       Date:  2016-03-10

9.  A 13-bp deletion in alpha(IIb) gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombasthenia.

Authors:  N Rosenberg; H Hauschner; H Peretz; R Mor-Cohen; M Landau; B Shenkman; G Kenet; B S Coller; A A Awidi; U Seligsohn
Journal:  J Thromb Haemost       Date:  2005-12       Impact factor: 5.824

10.  Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis.

Authors:  Amos Frisch; Roberto Colombo; Elena Michaelovsky; Mazal Karpati; Boleslaw Goldman; Leah Peleg
Journal:  Hum Genet       Date:  2004-01-15       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.